secwatch.observer — SEC 8-K summary
======================================

Issuer:     PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK:        0001401667
Form:       8-K
Filed at:   2023-01-09T23:59:59+00:00
Accession:  0001437749-23-000699
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Puma Biotechnology files 8-K for investor presentations; no material new info disclosed
--------------------------------------------------------------------------------

- Chairman, President & CEO Alan Auerbach to present at investor conferences starting Jan 9, 2023.
- Presentation materials furnished as Exhibit 99.1; no specific financial or operational updates in filing text.
- No earnings, guidance, or corporate events announced in this 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401667/000143774923000699/0001437749-23-000699-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401667/000143774923000699/pbyi20230105_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-000699

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer